Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients

NCT06162325 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Sponsor

Peking Union Medical College Hospital